HomeCTKB • NASDAQ
Cytek Biosciences Inc
add
$3.40
19.30%
Pre-market:(5.88%)+0.20
$3.60
Closed: Jun 5, 8:01:02 AM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 41.46M | -7.59% |
Operating expense | 35.13M | 4.10% |
Net income | -11.40M | -84.83% |
Net profit margin | -27.50 | -100.00% |
Earnings per share | -0.03 | -134.48% |
EBITDA | -13.10M | -44.99% |
Effective tax rate | -1.21% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 265.61M | -1.66% |
Total assets | 482.60M | -1.92% |
Total liabilities | 102.97M | 3.54% |
Total equity | 379.62M | — |
Shares outstanding | 126.66M | — |
Price to book | 0.96 | — |
Return on assets | -7.62% | — |
Return on capital | -9.26% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -11.40M | -84.83% |
Cash from operations | -125.00K | -103.16% |
Cash from investing | 9.45M | 264.27% |
Cash from financing | -11.55M | -815.75% |
Net change in cash | -3.45M | -328.06% |
Free cash flow | 3.73M | -61.60% |
Previous close
$2.85
Day range
$2.96 - $3.43
Year range
$2.37 - $7.63
Market cap
430.64M USD
Avg Volume
998.07K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1992
Website
Employees
663
